| Issue | Title | |
| Vol 13, No 2 (2017) | ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE | Abstract PDF (Rus) |
| V. I. Podzolkov, N. A. Dragomiretskaya | ||
| Vol 14, No 6 (2018) | Alexander D. Deev is 75 | Abstract PDF (Eng) |
| artilce Editorial | ||
| Vol 9, No 3 (2013) | ALGORITHM FOR MANAGEMENT OF HYPERTENSIVE PATIENTS UNDERWENT UROLOGY INTERVENTIONS | Abstract PDF (Rus) |
| S. S. Davydova | ||
| Vol 16, No 2 (2020) | Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation | Abstract PDF (Rus) |
| Yu. P. Skirdenko, N. A. Nikolaev | ||
| Vol 16, No 1 (2020) | Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease | Abstract PDF (Rus) |
| A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, G. A. Procenko | ||
| Vol 11, No 1 (2015) | ALL-RUSSIA RESEARCH/PRACTICE CONFERENCE “NON-INFECTIOUS DISEASES AND PUBLIC HEALTH IN RUSSIA” 28-29 MAY 2015, MOSCOW | Abstract PDF (Rus) |
| Vol 12, No 6 (2016) | ALL-RUSSIAN SCIENTIFIC AND PRACTICAL CONFERENCE "NON-COMMUNICABLE DISEASES AND THE HEALTH OF THE POPULATION OF RUSSIA", MAY 16-18, 2017, MOSCOW INFORMATION LETTER | Abstract PDF (Rus) |
| article editorial | ||
| Vol 8, No 4 (2012) | ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE | Abstract PDF (Rus) |
| S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina, A. G. Larin | ||
| Vol 3, No 2 (2007) | AMERICAN COLLEGE OF CARDIOLOGY, AMERICAN HEART ASSOCIATION AND EUROPEAN SOCIETY OF CARDIOLOGY (2006) GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION | Abstract PDF (Rus) |
| V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, J.Y. Le Heuzey, G.N. Kay, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, S. Wann | ||
| Vol 3, No 3 (2007) | AMERICAN COLLEGE OF CARDIOLOGY, AMERICAN HEART ASSOCIATION AND EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES (2006) FOR THE MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION (ENDING) | Abstract PDF (Rus) |
| V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, J.Y. Le Heuzey, G.N. Kay, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, S. Wann | ||
| Vol 4, No 5 (2008) | AMLODIPINE ADVANTAGES IN ARTERIAL HYPERTENSION THERAPY | Abstract PDF (Rus) |
| V. M. Tsareva, N. J. Hozjainova, M. S. Bezaltynnyh, T. V. Brook, N. A. Borohova, I. E. Koltunov, N. M. Ahmedzhanov | ||
| Vol 7, No 5 (2011) | AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION | Abstract PDF (Rus) |
| A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva | ||
| Vol 6, No 1 (2010) | AMLODIPINE IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON ANTIATHEROSCLEROTIC PROPERTIES | Abstract PDF (Rus) |
| Yu. M. Lopatin | ||
| Vol 16, No 1 (2020) | An Attempt to Accord the Quality of Therapy of Stable Coronary Heart Disease Patients with Current Clinical Guidelines (ALIGN study): Design and the First Results | Abstract PDF (Rus) |
| S. Yu. Martsevich, E. D. Zharkova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, A. V. Zagrebelnyy | ||
| Vol 16, No 6 (2020) | An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants? | Abstract PDF (Rus) |
| T. V. Pavlova | ||
| Vol 20, No 6 (2024) | An in-depth study of the association of breast arterial calcification with cardiovascular disease, its risk factors, and other chronic noncommunicable diseases: rationale and study protocol | Abstract PDF (Rus) PDF (Rus) |
| I. V. Kim, E. V. Bochkareva, E. K. Butina, O. V. Molchanova, N. Kh. Bayramkulova, E. M. Filichkina, E. B. Yarovaya, O. M. Drapkina | ||
| Vol 17, No 3 (2021) | An Integrated Approach to the Management of a Multimorbid Patient with Atrial Fibrillation from the Standpoint of Modern Guidelines: Rivaroxaban is in Focus | Abstract PDF (Rus) |
| V. N. Larina, O. Sh. Oynotkinova, A. P. Majorova, G. A. Egiazarian, T. Yu. Demidova | ||
| Vol 11, No 2 (2015) | AN OUTPATIENT WITH ATRIAL FIBRILLATION: KEY FEATURES. THE FIRST DATA OF REKVAZA FP - YAROSLAVL REGISTER | Abstract PDF (Rus) |
| V. V. Yakusevich, E. M. Pozdnyakova, Vl. .V. Yakusevich, V. A. Simonov, S. Yu. Martsevich, M. M. Loukianov, A. V. Zagrebelnyy, S. A. Boytsov | ||
| Vol 17, No 2 (2021) | Analysis of Anticoagulant Therapy in the Elderly Patients, in Clinical Practice of Family Medicine Centers in the Kyrgyz Republic | Abstract PDF (Rus) |
| S. M. Mamatov, B. Kanat kyzy, A. O. Musakeev, N. K. Kinderbaeva, T. J. Tagaev | ||
| Vol 10, No 2 (2014) | ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract PDF (Rus) |
| V. I. Petrov, O. V. Shatalova, A. S. Maslakov | ||
| Vol 8, No 1 (2012) | ANALYSIS OF COST STRUCTURE FOR PHARMACOTHERAPY OF PATIENTS WITH STABLE ANGINA (THE CASE OF CARDIOLOGY DEPARTMENT OF TVER REGIONAL CLINICAL HOSPITAL) | Abstract PDF (Rus) |
| M. A. Demidova, N. N. Kirilenko | ||
| Vol 7, No 5 (2011) | ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract PDF (Rus) |
| Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva | ||
| Vol 11, No 3 (2015) | ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I | Abstract PDF (Rus) |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta | ||
| Vol 3, No 5 (2007) | ANALYSIS OF PRE-HOSPITAL TREATMENT OF ACUTE CORONARY SYNDROME | Abstract PDF (Rus) |
| O. V. Reshetko, R. M. Magdeev, N. V. Furman | ||
| Vol 11, No 3 (2015) | ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract PDF (Rus) |
| A. V. Rudakova | ||
| Vol 11, No 6 (2015) | Analysis of the problem of low adherence of patients to attendance at outpatient clinics and cardiorehabilitation programs according to the data from published studies | Abstract PDF (Rus) |
| Yu. V. Semenova, N. P. Kutishenko, S. Yu. Martsevich | ||
| Vol 19, No 1 (2023) | Analysis of The Use of PCSK9 Inhibitors in Clinical Practice | Abstract PDF (Rus) |
| S. Yu. Volkova, L. A. Boyarskaya, P. Yu. Toropygin, I. A. Morozov, E. A. Boyarskaya | ||
| Vol 13, No 5 (2017) | ANATOLY I. MARTYNOV IS 80 YEARS OLD! | Abstract PDF (Rus) |
| статья Редакционная | ||
| Vol 20, No 3 (2024) | Anatoly Ivanovich Martynov (October 22, 1937 — May 19, 2024) | Abstract PDF (Rus) |
| article Editorial | ||
| Vol 16, No 6 (2020) | Anatoly N. Britov 15.01.1934-03.12.2020 | Abstract PDF (Rus) |
| article Editorial | ||
| Vol 17, No 4 (2021) | Andrey A. Kirichenko | Abstract PDF (Rus) |
| article editotial | ||
| Vol 16, No 3 (2020) | Angiogenesis in Patients with Chronic Heart Failure: Focus on Endothelial Vascular Growth Factor, Pentraxin-3 and Transforming Growth Factor Beta | Abstract PDF (Rus) |
| R. N. Shepel, O. M. Drapkina | ||
| Vol 13, No 3 (2017) | ANGIOSARCOMA OF THE HEART – CLINICAL CASE | Abstract PDF (Rus) |
| N. Yu. Karpova, M. A. Rashid, T. V. Kazakova, N. S. Chipigina, A. V. Aksenova, R. V. Ershov, Zh. I. Banova, E. M. Levin, A. A. Byshov, B. V. Uvarovskaya | ||
| Vol 9, No 4 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT | Abstract PDF (Rus) |
| S. Yu. Martsevich | ||
| Vol 9, No 2 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY | Abstract PDF (Rus) |
| S. Yu. Martsevich | ||
| Vol 14, No 6 (2018) | Angiotensin Converting Enzyme Inhibitors and the Risk of Lung Cancer – New Scientific Evidences or Another Example of “Pseudo-Evidence” Medicine? | Abstract PDF (Eng) |
| S. Yu. Martsevich | ||
| Vol 3, No 3 (2007) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? | Abstract PDF (Rus) |
| S. Y. Martsevich, S. N. Tolpygina | ||
| Vol 5, No 3 (2009) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE | Abstract PDF (Rus) |
| S. N. Tereshchenko, N. A. Dzhaiani | ||
| Vol 2, No 4 (2006) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract PDF (Rus) |
| K. Yu. Nikolaev, G. I. Lifshits, A. A. Nikolaeva, I. M. Gicheva | ||
| Vol 4, No 3 (2008) | ANGIOTENSIN II AND MYOCARDIAL INFARCTION | Abstract PDF (Rus) |
| O. P. Shevchenko, А. О. Shevchenko | ||
| Vol 6, No 1 (2010) | ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES | Abstract PDF (Rus) |
| E. M. Khurs, A. V. Poddubnaya | ||
| Vol 13, No 3 (2017) | ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION | Abstract PDF (Rus) |
| V. I. Podzolkov, M. V. Pisarev | ||
| Vol 12, No 6 (2016) | ANNUAL FORECAST IN PATIENTS WITH ACUTE ISCHEMIC STROKE: ROLE OF PATHOLOGICAL ANKLE-BRACHIAL INDEX | Abstract PDF (Rus) |
| A. N. Sumin, J. A. Kolmykova, I. N. Kukhareva, M. V. Ott, N. I. Vodopyanova, A. A. Morkvenas, O. A. Trubnikova, A. V. Kovalenko | ||
| Vol 5, No 5 (2009) | ANOTHER LOOK AT TYPE 2 DIABETES PATIENT: “DIALOGUE” STUDY RESULTS | Abstract PDF (Rus) |
| I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva, A. A. Sobolev, E. V. Rodygina | ||
| Vol 5, No 5 (2009) | ANTIAGGREGANT THERAPY OVERCOMES LIMITS | Abstract PDF (Rus) |
| I. Andreeva | ||
| Vol 18, No 2 (2022) | Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases | Abstract PDF (Rus) |
| A. N. Zakirova, N. E. Zakirova | ||
| Vol 12, No 4 (2016) | Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs | Abstract PDF (Rus) |
| E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva | ||
| Vol 12, No 5 (2016) | Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs | Abstract PDF (Rus) |
| E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva | ||
| Vol 7, No 1 (2011) | ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION | Abstract PDF (Rus) |
| R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov | ||
| Vol 5, No 4 (2009) | ANTIARRHYTMIC EFFICACY OF SOTALOL IN PATIENTS WITH TACHY-BRADY SYNDROME HAVING ATRIAL PACEMAKER WITH DIFFERENT ATRIAL ELECTRODE POSITION | Abstract PDF (Rus) |
| T. N. Novikova | ||
| Vol 15, No 5 (2019) | Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation | Abstract PDF (Rus) |
| O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko | ||
| Vol 14, No 6 (2018) | Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem | Abstract PDF (Eng) |
| N. M. Vorobyeva, O. N. Tkacheva | ||
| Vol 14, No 5 (2018) | Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable | Abstract PDF (Rus) |
| D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin | ||
| Vol 11, No 2 (2015) | ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY | Abstract PDF (Rus) PDF (Eng) |
| V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina | ||
| Vol 21, No 2 (2025) | Anticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation | Abstract PDF (Rus) |
| E. A. Naryshkina, M. I. Chashkina, E. S. Zadykyan, N. K. Kurbanalieva, E. M. Zakaryan, M. V. Serova, D. A. Andreev, A. G. Komarova, K. E. Eroshkin, A. A. Kulesh, D. A. Sychev | ||
| Vol 17, No 2 (2021) | Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions | Abstract PDF (Rus) |
| V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto | ||
| Vol 9, No 3 (2013) | ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT | Abstract PDF (Rus) |
| E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts | ||
| Vol 17, No 6 (2021) | Anticoagulants after Discharge in Patients with COVID-19: What we Know at the End of 2021 | Abstract PDF (Rus) |
| I. S. Yavelov | ||
| Vol 5, No 3 (2009) | ANTICOAGULANTS IN ACUTE CORONARY SYNDROME | Abstract PDF (Rus) |
| I. A. Latfullin, A. A. Podolskaya | ||
| Vol 4, No 2 (2008) | ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN? | Abstract PDF (Rus) |
| A. L. Komarov, E. P. Panchenko | ||
| Vol 17, No 2 (2021) | Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage | Abstract PDF (Rus) |
| A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov | ||
| Vol 6, No 3 (2010) | ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY | Abstract PDF (Rus) |
| V. A. Nevzorova, E. S. Potapova, O. V. Nastradin | ||
| Vol 15, No 4 (2019) | Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination | Abstract PDF (Rus) |
| O. D. Ostroumova, A. I. Kochetkov | ||
| Vol 15, No 4 (2019) | Antihypertensive Drug Utilization in Two Districts of Northern Cyprus | Abstract PDF (Eng) PDF (Rus) |
| M. Tamirci, R. Demirdamar | ||
| Vol 9, No 3 (2013) | ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION OF VALSARTAN AND VALSARTAN AND HYDROCHLOROTHIAZIDE COMBINATION IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION | Abstract PDF (Rus) |
| V. I. Podzolkov, A. V. Vigdorchik | ||
| Vol 6, No 1 (2010) | ANTIHYPERTENSIVE EFFICACY AND VASOPROTECTIVE PROPERTIES OF A NEW COMBINATION OF BETA-BLOCKER, BISOPROLOL (2,5/5 MG) AND DIURETIC, HYDROCHLOROTHIAZIDE (6,25 MG) | Abstract PDF (Rus) |
| O. D. Ostroumova, A. G. Sazonova, K. U. Reznikova, A. V. Srednjakov, E. A. Smolyarchuk | ||
| Vol 14, No 6 (2018) | Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk | Abstract PDF (Eng) |
| O. Yu. Korennova, S. P. Podolnaya, E. P. Prihodko, E. A. Turusheva, S. N. Starinskaya, I. A. Вratishko, I. V. Druk | ||
| Vol 6, No 1 (2010) | ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY | Abstract PDF (Rus) |
| V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik | ||
| Vol 4, No 4 (2008) | ANTIHYPERTENSIVE EFFICACY OF VERAPAMIL PLUS INDAPAMIDE IN PATIENTS WITH METABOLIC SYNDROME | Abstract PDF (Rus) |
| E. M. Idrisova, T. P. Kalashnikova, E. I. Mananko, E. V. Vorobyeva | ||
| Vol 1, No 2 (2005) | ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract PDF (Rus) |
| M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov | ||
| Vol 4, No 4 (2008) | ANTIHYPERTENSIVE THERAPY AND CLIMACTERIC DISORDERS IN POSTMENOPAUSAL WOMEN | Abstract PDF (Rus) |
| A. A. Kirichenko, Z. M. Tankieva | ||
| Vol 4, No 5 (2008) | ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS | Abstract PDF (Rus) |
| T. V. Adasheva, I. V. Fedorova, V. S. Zadionchenko, M. V. Macievich, V. V. Lee, S. V. Pavlov | ||
| Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT IN ELDERLY PATIENTS WITH DIHYDROPYRIDINE CALCIUM ANTAGONISTS | Abstract PDF (Rus) |
| Y. A. Karpov, V. V. Buza | ||
| Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE | Abstract PDF (Rus) |
| R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov | ||
| Vol 7, No 6 (2011) | ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS | Abstract PDF (Rus) |
| L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo | ||
| Vol 15, No 4 (2019) | Antimicrobial Treatment of Infective Endocarditis, Caused by Enterococcus Faecalis | Abstract PDF (Eng) |
| E. V. Shikh, T. E. Morozova, V. N. Drozdov, N. B. Lazareva, D. A. Shatsky, T. B. Andrushchyshina, M. V. Lukina, O. A. Vartanova | ||
| Vol 5, No 3 (2009) | ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract PDF (Rus) |
| E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva | ||
| Vol 9, No 6 (2013) | ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS? | Abstract PDF (Rus) |
| Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein | ||
| Vol 13, No 1 (2017) | ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY | Abstract PDF (Rus) |
| E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko | ||
| Vol 4, No 2 (2008) | ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION | Abstract PDF (Rus) |
| D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov | ||
| Vol 17, No 4 (2021) | Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Abstract PDF (Rus) |
| A. V. Panov | ||
| Vol 14, No 4 (2018) | Antithrombotic Therapy after Bleeding in Elderly Polimorbid Patient: Our Time Challenge | Abstract PDF (Rus) |
| M. R. Atabegashvili, M. Yu. Gilyarov, E. V. Konstantinova, A. N. Kostina, A. P. Nesterov, T. D. Pakharkova, A. E. Udovichenko | ||
| Vol 18, No 2 (2022) | Antithrombotic Therapy and the Nearest Forecast of Pulmonary Embolism in Rutine Clinical Practice (Data of the Regional Vascular Center of the Ryazan Region) | Abstract PDF (Rus) |
| N. N. Nikulina, Yu. V. Terekhovskaya, S. S. Yakushin | ||
| Vol 6, No 1 (2010) | ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS | Abstract PDF (Rus) |
| M. Yu. Gilyarov, V. A. Sulimov | ||
| Vol 4, No 3 (2008) | ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS | Abstract PDF (Rus) |
| V. A. Sulimov | ||
| Vol 7, No 1 (2011) | ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS | Abstract PDF (Rus) |
| M. Yu. Gilyarov, V. A. Sulimov | ||
| Vol 7, No 5 (2011) | ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES | Abstract PDF (Rus) |
| Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy | ||
| Vol 6, No 4 (2010) | ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS | Abstract PDF (Rus) |
| A. Y. Rychkov, N. Y. Khor'kova, A. A. Bliznyakov | ||
| Vol 14, No 6 (2018) | Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice | Abstract PDF (Eng) |
| K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova | ||
| Vol 21, No 3 (2025) | Antithrombotic therapy in patients with atrial fibrillation hospitalised with myocardial infarction in 2016-2023: timeliness of clinical guideline adherence | Abstract PDF (Rus) |
| K. G. Pereverzeva, S. S. Yakushin, N. A. Kindyakova, P. R. Mamedov | ||
| Vol 19, No 2 (2023) | Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment | Abstract PDF (Rus) |
| O. R. Eshmatov, M. S. Khlynin, R. E. Batalov, E. A. Archakov, I. V. Kisteneva | ||
| Vol 2, No 3 (2006) | ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? | Abstract PDF (Rus) |
| I. A. Latfullin, A. A. Podolskaya | ||
| Vol 9, No 2 (2013) | ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS | Abstract PDF (Rus) |
| O. V. Shatalova, O. N. Smuseva, A. S. Maslakov | ||
| Vol 4, No 3 (2008) | ANXIETY AND DEPRESSION IN INTERNAL MEDICINE | Abstract PDF (Rus) |
| A. V. Fedotova | ||
| Vol 2, No 3 (2006) | APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY | Abstract PDF (Rus) |
| S. V. Nedogoda | ||
| Vol 12, No 4 (2016) | Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation | Abstract PDF (Rus) |
| S. G. Kanorskii | ||
| Vol 9, No 5 (2013) | APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA | Abstract PDF (Rus) |
| D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev | ||
| Vol 9, No 6 (2013) | APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY | Abstract PDF (Rus) |
| D. A. Sychev, G. N. Shuev, A. B. Prokofiev | ||
| Vol 13, No 2 (2017) | APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION | Abstract PDF (Rus) |
| E. A. Ushkalova, S. K. Zyryanov, E. V. Dumchenko | ||
| Vol 17, No 4 (2021) | Approaches to Assessing the Quality of Observational Studies of Clinical Practice Based on the Big Data Analysis | Abstract PDF (Rus) |
| S. R. Gilyarevsky | ||
| 101 - 200 of 2251 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
Browse Title Index
Popular articles
Vol 11, No 3 (2015)
Vol 14, No 5 (2018)
Vol 6, No 2 (2010)
Vol 13, No 5 (2017)
Vol 17, No 5 (2021)
Editor-in-Chief
Drapkina O. M.
Keywords
acute coronary syndrome
acute myocardial infarction
amlodipine
apixaban
arterial hypertension
atherosclerosis
atrial fibrillation
cardiovascular diseases
cardiovascular risk
chronic heart failure
dabigatran
heart failure
hypertension
ischemic heart disease
metabolic syndrome
myocardial infarction
obesity
risk factors
rivaroxaban
statins
warfarin
Moscow 101990, Russia
Petroverigsky per. 10
Tel.: +7 (499) 553 68 10
е-mail: otsec.rfc@mail.ru
